Pricing Log in Create free account

GlucoTrack, Inc. (GCTK) vs Regentis Biomaterials Ltd. (RGNT)

GlucoTrack, Inc. and Regentis Biomaterials Ltd. are both Medical Instruments & Supplies companies. Regentis Biomaterials Ltd. is the larger, with a market value of $10.9M against $840.0K — 13.0× the size. Across the 7 metrics below, Regentis Biomaterials Ltd. leads on 4 and GlucoTrack, Inc. on 3.

Valuation

Metric GCTK RGNT Medical Instruments & Supplies median
P/E n/m — 33.75
P/S 1.17 — 2.52
P/B n/m n/m 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales 5.10 n/m 2.88
Earnings yield (18,853.56%) — (2.67%)
Free cash flow yield (6,690.23%) 0.00% 0.09%

Profitability

Metric GCTK RGNT Medical Instruments & Supplies median
Gross margin 0.00% — 54.29%
Operating margin 0.00% — 1.07%
Net margin 0.00% — (1.61%)
Free cash flow margin 0.00% 0.00% 1.08%
Return on equity (620.63%) 0.00% (1.32%)
Return on assets (272.48%) 0.00% 0.00%
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GCTK RGNT Medical Instruments & Supplies median
Revenue growth (TTM) (60.61%) — 8.85%
EPS growth (last fiscal year) 99.24% (1,504.65%) 8.65%
Revenue growth, 5-year CAGR 28.31% — 9.17%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GCTK RGNT Medical Instruments & Supplies median
Debt to equity (1.11) 0.00 0.10
Current ratio 0.46 5.62 2.48
Net debt to EBITDA 0.25 0.89 0.89

Dividend

Metric GCTK RGNT Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric GCTK RGNT Medical Instruments & Supplies median
Market cap 840.00k 10.89m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack